Protein fingerprint may forecast liver cancer 15 years early

This study looks at stored liver biopsy samples from 30 people with MASH (a fatty liver disease) to see if a protein test can predict who will develop liver cancer within 15 years. Half of the participants later got liver cancer, and half did not. Researchers will compare the proteins in their biopsies to find a pattern that signals future cancer risk. If successful, this could lead to earlier detection and better monitoring for high-risk patients.